The Board of Elan Corporation, plc ELN (Elan) notes today's
announcement regarding the revised offer by Echo Pharma Acquisition Limited
(“Royalty Pharma”) to acquire Elan's shares under Rule 2.5 of the Irish
Takeover Rules.
The Board of Elan will, as before, in line with its obligations under Irish
Takeover law, assess the Royalty Pharma announcement and will advise its
shareholders accordingly. In the meantime, Elan shareholders are strongly
advised to take no action in relation to the Royalty Pharma offer.
The Directors of Elan accept responsibility for the information contained in
this announcement. To the best of their knowledge and belief (having taken all
reasonable care to ensure such is the case), the information contained in this
announcement is in accordance with the facts and does not omit anything likely
to affect the import of such information.
Any holder of 1% or more of any class of relevant securities of Elan or of
Royalty Pharma may have disclosure obligations under Rule 8.3 of the Irish
Takeover Panel Act, 1997, Takeover Rules 2007 (as amended).
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in